"IO Biotech enrols all subjects in Phase II trial of cancer combination therapy" was originally created and published by ...

When Kristen Dahlgren left journalism to launch a cancer vaccine initiative, she never imagined it would reconnect her with ...

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile became crooked.

Approximately 11,500 new cases of cervical cancer are diagnosed each year and, sadly, roughly 4,000 women will succumb to the disease, according to the Centers for Disease Control and Prevention. But ...

IO Biotech, Inc. (IOBT), a clinical-stage biopharmaceutical company, Thursday, announced that it has completed enrollment ahead of ...

January marks Cervical Cancer Awareness Month, a time to focus on the importance of prevention and early detection. One of ...

The concept of vaccines first emerged in the 18th century when Dr. Edward Jenner purposely gave a young boy cowpox. Jenner, ...

CVGBM, an investigational cancer vaccine, induced T-cell responses in patients with MGMT-unmethylated glioblastoma.

The Brian and Sheila Jellison Family Foundation is proud to be the first major donor to support Cancer Vaccine Coalition (CVC ...

Cancer remains a leading cause of death in the U.S., affecting 1 in 3 people, but many are surviving and thriving after ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.